Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT01976741
Title	Phase I Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor
Recruitment	Completed
Gender	both
Phase	Phase I
Variant Requirements	Yes
Sponsors	Bayer
Indications	lung adenocarcinoma lung non-small cell carcinoma lung squamous cell carcinoma urinary bladder cancer head and neck cancer Advanced Solid Tumor
Therapies	Rogaratinib
Age Groups:	adult \| senior
Covered Countries	USA \| FRA \| ESP \| DEU